These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28665159)

  • 1. New drugs or alternative therapy to blurring the symptoms of fibromyalgia-a patent review.
    Oliveira MA; Guimarães AG; Araújo AAS; Quintans-Júnior LJ; Quintans JSS
    Expert Opin Ther Pat; 2017 Oct; 27(10):1147-1157. PubMed ID: 28665159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential drug therapies for the treatment of fibromyalgia.
    Lawson K
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1071-81. PubMed ID: 27269389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrins: improving the therapeutic response of analgesic drugs: a patent review.
    de Oliveira MG; Guimarães AG; Araújo AA; Quintans JS; Santos MR; Quintans-Júnior LJ
    Expert Opin Ther Pat; 2015; 25(8):897-907. PubMed ID: 25960079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives for chronic pain treatment: a patent review (2010-2016).
    Pina LTS; Gouveia DN; Costa JS; Quintans JSS; Quintans-Júnior LJ; Barreto RSS; Guimarães AG
    Expert Opin Ther Pat; 2017 Jul; 27(7):787-796. PubMed ID: 28597731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on emerging drugs for fibromyalgia treatment.
    Atzeni F; Gerardi MC; Masala IF; Alciati A; Batticciotto A; Sarzi-Puttini P
    Expert Opin Emerg Drugs; 2017 Dec; 22(4):357-367. PubMed ID: 29250975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technological development of microemulsions with perspectives for pain treatment: a patent review.
    Lima MPD; Lopes EM; Gomes LDS; França ARS; Acha BT; Carvalho ALM; Almeida FRC
    Expert Opin Ther Pat; 2018 Sep; 28(9):691-702. PubMed ID: 30175633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapies for fibromyalgia: an update.
    Ablin JN; Buskila D
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):521-33. PubMed ID: 20486862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery and development for fibromyalgia using practical biomarkers throughout the process from relevant animal models to patients.
    Nagakura Y; Tozaki-Saitoh H; Takeda H
    Expert Opin Drug Discov; 2023 May; 18(5):539-549. PubMed ID: 37051616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of fibromyalgia and its symptoms.
    Staud R
    Expert Opin Pharmacother; 2007 Aug; 8(11):1629-42. PubMed ID: 17685881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapies for fibromyalgia.
    Ablin JN; Buskila D
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):53-62. PubMed ID: 18321148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study.
    Arnold LM; Sarzi-Puttini P; Arsenault P; Khan T; Bhadra Brown P; Clair A; Scavone JM; Driscoll J; Landen J; Pauer L
    J Rheumatol; 2015 Jul; 42(7):1237-44. PubMed ID: 26034150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Emerging Pharmacotherapy for Fibromyalgia.
    Tzadok R; Ablin JN
    Pain Res Manag; 2020; 2020():6541798. PubMed ID: 32104521
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent trends in neuropathic pain patents.
    Maia RD
    Expert Opin Ther Pat; 2017 May; 27(5):539-546. PubMed ID: 27998196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms.
    Perrot S; Russell IJ
    Eur J Pain; 2014 Sep; 18(8):1067-80. PubMed ID: 25139817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium oxybate for the treatment of fibromyalgia.
    Staud R
    Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia.
    Arnold L; Mease P; Silverman S
    Am J Manag Care; 2010 May; 16(5 Suppl):S138-43. PubMed ID: 20586522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
    Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study.
    Arnold LM; Schikler KN; Bateman L; Khan T; Pauer L; Bhadra-Brown P; Clair A; Chew ML; Scavone J;
    Pediatr Rheumatol Online J; 2016 Jul; 14(1):46. PubMed ID: 27475753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.